Literature DB >> 28567196

Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study.

Daniel W Gunda1, Kahamba G Godfrey1, Semvua B Kilonzo1, Bonaventura C Mpondo2.   

Abstract

BACKGROUND: HIV/AIDS causes high morbidity and mortality through both immunosuppression and complications not directly related to immunosuppression. Haematological abnormalities, including various cytopenias, occur commonly in HIV through immune and non-immune pathways. Though these complications could potentially cause serious clinical implications, published literature on the magnitude of this problem and its associated factors in Tanzania is scarce. This study aimed at determining the prevalence and risk factors of HIV-associated cytopenias among ART-naive patients enrolling for care and treatment services at Bugando Care and Treatment Centre (CTC) in Mwanza, Tanzania.
METHODS: This was a cross-sectional clinic-based study done between March 2015 and February 2016, involving all antiretroviral therapy (ART)-naive adult HIV-positive patients enrolling for care and treatment services at Bugando CTC. Patients younger than 18 years and those with missing data were excluded. Data were analysed using Stata version 11 to determine the prevalence and risk factors of cytopenias.
RESULTS: A total of 1205 ART-naive patients were included. Median age was 41 years (interquartile range [IQR] 32 to 48). Most participants were female (n = 789; 65.6%), with a female-to-male ratio of 2:1. The median baseline CD4 count was 200 cells/µL (IQR 113 to 439). About half (49%) of the study participants had baseline CD4 counts less than 200 cells/µL. Anaemia, leucopenia, and thrombocytopenia were found in 704 (58.4%), 285 (23.6%), and 174 (14.4%) participants, respectively, and these were strongly associated with advanced HIV infection.
CONCLUSIONS: The magnitude of cytopenias is high among ART-naive HIV-positive adults, and cytopenias are more marked with advanced HIV infection. Early diagnosis of HIV and timely initiation of ART could potentially reduce the number of people living with advanced HIV disease and its associated complications, including the cytopenias investigated in this study. Patients with cytopenias should undergo thorough screening for tuberculosis, which is an important and treatable correlate of cytopenia, in addition to close follow-up for any potential negative outcomes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28567196      PMCID: PMC5442491          DOI: 10.4314/mmj.v29i1.9

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  65 in total

1.  [HIV-associated thrombocytopenia].

Authors:  J Jost; M G Täuber; R Lüthy; W Siegenthaler
Journal:  Schweiz Med Wochenschr       Date:  1988-02-13

Review 2.  The influence of human immunodeficiency virus-1 on hematopoiesis.

Authors:  A Moses; J Nelson; G C Bagby
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

3.  Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania.

Authors:  Megan E O'Brien; Roland Kupka; Gernard I Msamanga; Elmar Saathoff; David J Hunter; Wafaie W Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

4.  Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia.

Authors:  Aristotelis Tsiakalos; John G Routsias; Theodore Kordossis; Haralampos M Moutsopoulos; Athanasios G Tzioufas; Nikolaos V Sipsas
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

5.  Late-stage disease at presentation to an HIV clinic in eastern Tanzania: A retrospective cross-sectional study.

Authors:  H Mhozya; D Bintabara; S Kibusi; E Neilson; B C Mpondo
Journal:  Malawi Med J       Date:  2015-12       Impact factor: 0.875

Review 6.  Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature.

Authors:  Pamela S Belperio; David C Rhew
Journal:  Am J Med       Date:  2004-04-05       Impact factor: 4.965

7.  Thrombocytopenia in HIV-Infected Patients.

Authors:  Francielle Garcia Nascimento; Paula Yurie Tanaka
Journal:  Indian J Hematol Blood Transfus       Date:  2011-10-20       Impact factor: 0.900

8.  Anemia in HIV infection: clinical impact and evidence-based management strategies.

Authors:  Paul A Volberding; Alexandra M Levine; Douglas Dieterich; Donna Mildvan; Ronald Mitsuyasu; Michael Saag
Journal:  Clin Infect Dis       Date:  2004-04-27       Impact factor: 9.079

9.  Poor diet quality is associated with low CD4 count and anemia and predicts mortality among antiretroviral therapy-naive HIV-positive adults in Uganda.

Authors:  Rahul Rawat; Sandra I McCoy; Suneetha Kadiyala
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

10.  Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania.

Authors:  Asgeir Johannessen; Ezra Naman; Svein G Gundersen; Johan N Bruun
Journal:  BMC Infect Dis       Date:  2011-07-11       Impact factor: 3.090

View more
  9 in total

1.  Immuno-Haematological Abnormalities of HIV-Infected Patients Before and After Initiation of Highly Active Antiretroviral Therapy in the Antiretroviral Therapy Clinics of Six Health Facilities at Dessie Town, Northeast Ethiopia.

Authors:  Mihret Tilahun; Alemu Gedefie; Endris Ebrahim; Abdurahaman Seid; Abdurrahman Ali; Agumas Shibabaw; Melaku Ashagrie Belete; Mesfin Fiseha; Melkam Tesfaye; Hussen Ebrahim; Admasu Abera
Journal:  J Blood Med       Date:  2022-05-11

2.  Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: A cross-sectional study.

Authors:  Negesso Duguma; Girum Tesfaye Kiya; Wondimagegn Adissu Maleko; Lealem Gedefaw Bimerew
Journal:  SAGE Open Med       Date:  2021-05-28

3.  Magnitude and associated factors of cytopenias among antiretroviral therapy naïve Human Immunodeficiency Virus infected adults in Dessie, Northeast Ethiopia.

Authors:  Zemenu Tamir; Abdurahaman Seid; Haftay Haileslassie
Journal:  PLoS One       Date:  2019-02-13       Impact factor: 3.240

4.  Prevalence of anemia among people living with HIV: A systematic review and meta-analysis.

Authors:  Guiying Cao; Yaping Wang; Yu Wu; Wenzhan Jing; Jue Liu; Min Liu
Journal:  EClinicalMedicine       Date:  2022-01-26

5.  Prevalence and Predictors of Cytopenias in HIV-Infected Adults at Initiation of Antiretroviral Therapy in Mehal Meda Hospital, Central Ethiopia.

Authors:  Temesgen Fiseha; Hussen Ebrahim
Journal:  J Blood Med       Date:  2022-04-26

6.  Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia.

Authors:  Angesom Gebreweld; Temesgen Fiseha; Nibret Girma; Haftay Haileslasie; Daniel Gebretsadik
Journal:  PLoS One       Date:  2020-09-15       Impact factor: 3.240

7.  Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).

Authors:  Menard L Chihana; Helena Huerga; Gilles Van Cutsem; Tom Ellman; Eric Goemaere; Stephen Wanjala; Charlie Masiku; Elisabeth Szumilin; Jean-Francois Etard; David Maman; Mary-Ann Davies
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

8.  Prevalence and Risk Factors of Cytopenia in HIV-Infected Patients before and after the Initiation of HAART.

Authors:  Lina Fan; Cuilin Li; Hongxin Zhao
Journal:  Biomed Res Int       Date:  2020-01-28       Impact factor: 3.411

9.  The hematologic profile of Filipino HIV-infected individuals and its association with CD4 counts.

Authors:  Preeti Prerna M Vaswani; Issa Rufina Senga-Tang; Jean Rachel M Catapia; Cybele Lara R Abad; Teresita E Dumagay
Journal:  Hematol Transfus Cell Ther       Date:  2021-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.